МП-ДГРСИВ | Access and Benefit-Sharing Clearing-House
× Please note that the translation of the ABS Clearing-House is in progress.
Механизм посредничества для регулирования доступа к генетическим ресурсам и совместного использования выгод (МП-ДГРСИВ) — это платформа для обмена информацией по вопросам доступа к генетическим ресурсам и совместного использования выгод и основной инструмент, содействующий осуществлению Нагойского протокола. Узнать больше


23 янв 2023
Webinar: Overview of new and improved clearing-house features

31 January 2023, 09:00 AM to 10:00 AM EST

17 янв 2023
Nomination of experts

Parties and observers are invited to nominate experts to participate in the ad hoc technical expert group on indicators for the Kunming-Montreal Global Biodiversity Framework

17 дек 2022

Сторона Nagoya Protocol

JavaScript chart by amCharts 3.21.6
Отказ от ответственности

Национальные записи

Recently published
01 фев 2023 Sra. Jessica María Amanzo Alcántara

Cartagena Protocol National Focal Point | ABS National Focal Point

National Focal Point Peru chm-nfp-pe-263028-4
31 янв 2023 Ms. Birgit Winkel

ABS National Focal Point

National Focal Point Germany chm-nfp-de-238179-12
30 янв 2023 Dr. Abiyot Berhanu

ABS National Focal Point

National Focal Point Ethiopia chm-nfp-et-254918-6
26 янв 2023 1-10


Checkpoint Communiqué Japan absch-cpc-jp-262985-2

Справочные записи

Recently published
16 янв 2023 CABI Switzerland's Best Practice for Access and Benefit Sharing Compliance

Contents 1. CABI’s ABS Policy and Best Practices 1 1.1 How CABI uses genetic material 1 1.2 Benefits CABI provides from its use of genetic material 2 2. Swiss legislation in relation to Access and Benefit Sharing (ABS) 2 3. CABI’s Best Practices and implementation in Switzerland 2 3.1 Accessing genetic resources for use (in situ) 3 3.2 Receiving biological and genetic resources from collaborators, collections or other providers (ex situ) 5 3.3 Transferring genetic material and/or resources outside of CABI 5 3.4 Enforcement and compliance 5 Annex 1: A glossary of useful terms and their definitions 6 Annex 2. Decision tree outlining the general steps of the CABI best practice. 8 Annex 3. CABI genetic resources database with an example entry 9 Annex 4. CABI generic MTA for supply of genetic resources 10

17 дек 2022 BROGOTA PROJECT ABS AROUND THE WORLD: The Brazilian law contrasted with international regulations (Dec 2022)

New updated edition of this comprehensive global survey of national ABS regulations, highlights the continuous progress in the establishment and implementation of national ABS regulations around the world.

Virtual Library Resource absch-vlr-scbd-262696-3
12 дек 2022 Wellcome Sanger Institute Best Practice - the Nagoya Protocol and Access and Benefit Sharing (ABS)

This document has been produced in order to provide assurance to Nagoya Protocol member states, regulators, researchers, collaborators and peers, that the Wellcome Sanger Institute has initiated and carries out appropriate processes and procedures to enable compliance with global Access and Benefit Sharing (hereafter; ABS) measures and compliance with the UK ABS legislation5 implementing the Nagoya Protocol1 for scientific research undertaken. Within this document are the tools, processes and procedures, comprising Institute policy, that when employed correctly staff and associates of the Wellcome Sanger Institute can be confident that they are conducting their research in accordance with the UK ABS legislation and in turn, ABS legislation in force globally.


The Bio-Cultural Community Protocol of the Ogiek peoples provides an insight into important social and cultural values of our people. It highlights and documents our traditional knowledge, way of life, customary laws and the key elements of Free Prior Informed Consent (FPIC) when engaging with external actors such as government, research Institutions, pharmaceutical companies and other private investors.